Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers

Novel biomarkers for tumour burden and bone disease are required to guide clinical management of plasma cell dyscrasias. Recently, bone turnover markers (BTMs) and Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) have been explored, although their role in the prospective assessment of multiple...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2022-12, Vol.15 (1), p.95
Hauptverfasser:	Agarwal, Gaurav, Nador, Guido, Varghese, Sherin, Getu, Hiwot, Palmer, Charlotte, Watson, Edmund, Pereira, Claudio, Sallemi, Germana, Partington, Karen, Patel, Neel, Soundarajan, Rajkumar, Mills, Rebecca, Brouwer, Richard, Maritati, Marina, Shah, Aarti, Peppercorn, Delia, Oppermann, Udo, Edwards, Claire M, Rodgers, Christopher T, Javaid, Muhammad Kassim, Gooding, Sarah, Ramasamy, Karthik
Format:	Artikel
Sprache:	eng
Schlagworte:	Benign monoclonal gammopathy Biological markers Biomarkers Blood diseases Bone diseases Bone imaging Bone loss Bone marrow Bone mineral density Bone turnover Chemotherapy Collagen Diagnosis Dkk1 protein Feasibility studies Fractures Health aspects Ligands Light chains Magnetic resonance imaging Methods Monoclonal gammopathy Morbidity Multiple myeloma Osteoprotegerin Patients Plasma Remission SOST protein Tumors Variance analysis Working groups
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!